Connect with us

Invega (paliperidone)

Paliperidone (or INVEGA®) is mainly prescribed to treat bipolar disorderschizophrenia, and schizoaffective disorder.

FDA Approval: 2006

Dosage Forms: 3 mg, 6 mg, 9 mg, 12 mg

Biological Half-life: 23 hours (oral)

Side Effects: Headache, tachycardia, insomnia, hyperprolactinaemia, cough, weight gain, indigestion, movement problems

Routes of Administration: Oral, IM

Pregnancy Category: C (US)

Like Us